Skip to main content

Table 1 Clinical characteristics of study subjects

From: Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

  Total 30 mix Basal Bolus p
n 42 21 21  
Male(%) 31 (73.8) 16 (76.2) 15 (71.4) 0.73
Age (y) 64.5 (56.8–71.0) 63.0 (55.5–71.0) 65.0 (59.0–70.5) 0.65
BMI(kg/m2) 23.7 (21.9–26.1) 23.8 (21.7–26.3) 23.5 (22.4–26.3) 0.79
HbA1c(%) 9.2 (7.9–10.6) 9.3 (8.1–11.3) 8.9 (7.7–10.0) 0.24
Duration of SU drug use (y) 11.0 (6.0–15.3) 11.0 (5.0–16.5) 10.0 (6.5–15.0) 0.76
  1. Data are expressed as frequencies (%), or median (inter quartile range). The sex ratio between the groups were compared using chi-square test. The medians of other data were compared using Wilcoxon rank-sum test. BMI: Body Mass Index. SU: sulfonylurea.